高级检索
    李文瑜, 陈菲莉. 利妥昔单抗维持治疗可提高滤泡淋巴瘤无进展生存率[J]. 循证医学, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
    引用本文: 李文瑜, 陈菲莉. 利妥昔单抗维持治疗可提高滤泡淋巴瘤无进展生存率[J]. 循证医学, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
    shu
    Reviewer: LI Wen-yu, CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
    Citation: Reviewer: LI Wen-yu, CHEN Fei-li. Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 83-84. DOI: 10.12019/j.issn.1671-5144.2020.02.005
    shu

    利妥昔单抗维持治疗可提高滤泡淋巴瘤无进展生存率

    Follicular Lymphoma Patients Could Benefit from Rituximab Maintenance

      摘要
      • HTML全文
      • 参考文献(2)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回